Other
Net Change in Cash
Kailera Therapeutics Net Change in Cash increased by 33.3% to -$48.44M in Q1 2026 compared to the prior quarter. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
StatementCash Flow Statement
SectionOther
CategoryLiquidity
SignalHigher is better
VolatilityVolatile
First reportedQ1 2025
Last reportedQ1 2026May 26, 2026
How to read this metric
A positive change indicates net cash generation, while a negative change indicates cash consumption for the period.
Detailed definition
The total net increase or decrease in cash, cash equivalents, and restricted cash during the reporting period. It is the...
Peer comparison
A fundamental liquidity metric used to compare cash management efficiency across all public companies.
Metric ID:
net_change_in_cashHistorical Data
2 periods
| Q1 '25 | Q1 '26 | |
|---|---|---|
| Value | -$72.64M | -$48.44M |
| QoQ Change | — | +33.3% |
| YoY Change | — | +33.3% |
Range-$72.64M – -$48.44M
Avg YoY Growth+33.3%
Median YoY Growth+33.3%
Net Change in Cash at Other Companies
Frequently Asked Questions
- What is Kailera Therapeutics 's net change in cash?
- Kailera Therapeutics (KLRA) reported net change in cash of -$48.44M in Q1 2026.
- What does net change in cash mean?
- The total change in the company's cash position over the period.